01:59 , Nov 22, 2008 |  BC Extra  |  Financial News

Argos raises $35.2 million

Argos (Durham, N.C.) completed a series C round, in which it raised $35.2 million. The financing was led by TVM Capital, with participation from new investors Mizuho Capital; Morningside Group; and Japan Asia Investment, as...
01:10 , Apr 24, 2008 |  BC Extra  |  Financial News

Argos raising $35.2 million

Argos (Durham, N.C.) raised an undisclosed amount in the first tranche of a planned $35.2 million series C round led by existing investor TVM Capital. New investors Mizuho Capital; Morningside Group; and Japan Asia Investment...
00:13 , Jul 13, 2007 |  BC Extra  |  Financial News

TargeGen raises $40 million

TargeGen (San Diego, Calif.) raised $40 million in a series D round. New investors Innovis Investments; VantagePoint Venture Partners; and CTI Life Sciences Fund joined existing investors Forward Ventures; Enterprise Partners; Chicago Growth Partners; CDP...
02:23 , Mar 7, 2007 |  BC Extra  |  Financial News

PainCeptor raises C$24.4 million

Neurology company PainCeptor (Montreal, Quebec) raised C$24.4 million (US$20.8 million) in a series B round. Investors included Desjardins Venture Capital; CDP Capital; T2C2/Bio 2000; Business Development Bank of Canada; and Lothian Partners. PainCeptor has two...
01:24 , Dec 1, 2006 |  BC Extra  |  Financial News

Xanthus raises $25 million

Cancer company Xanthus ( Cambridge , Mass.) raised $25 million in another tranche of its series B round. Investors in the current tranche included Oxford Bioscience Partners; HealthCare Ventures; GeneChem; GIMV; Hambrecht & Quist Capital...
07:00 , Jun 19, 2006 |  BioCentury  |  Finance

Ebb & Flow

Investors gave a cool response to Intercell’s news that it had signed a deal covering its Japanese encephalitis vaccine with Novartis (NVS; SWX:NOVN). The agreement includes milestones up to E37 million ($46.7 million) split almost...
07:00 , Aug 1, 2005 |  BC Week In Review  |  Company News

Enobia Phase Inc. board of directors update

Enobia Phase Inc. , Montreal, Quebec   Business: Musculoskeletal   Appointed: Yvon Bastien, formerly president of sanofi-aventis Group's Sanofi Synthelabo Canada unit; Sylvie Bouchard, VP of clinical development and regulatory affairs at Labopharm Inc.; Max...
07:00 , Jul 18, 2005 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Innodia Inc. Laval, Quebec Technology: Small molecules to treat and prevent Type II diabetes Disease focus: Metabolic Clinical status: Phase Ib Founded: 2002 by Claude Vezeau and Francois Mongrain University collaborators: McGill University , Bar-Ilan...
07:00 , May 23, 2005 |  BioCentury  |  Finance

Ebb & Flow

This year's American Society of Clinical Oncology conference saw muted moves compared with the run up in the months preceding last year's conference and the hosing that cancer companies received during and after last year's...
00:34 , May 20, 2005 |  BC Extra  |  Financial News

Gemin X raises $50 million

Gemin X (Montreal, Canada) raised $50 million in a series D round co-led by H.I.G. Ventures and Sanderling. New investors Merlin BioMed Group and Pinnacle Biotech Ventures joined ProQuest Investments; Softbank; HBM BioVentures; MDS Capital;...